Introduction to Sustainable Biotech
Paris-based baCta, an industrial biotech startup, has secured €7 million in seed funding. This investment will support the scale-up of baCta’s first product, astaxanthin, and accelerate the deployment of baCtaForge, its strain engineering platform.
Challenges in Industrial Ingredient Production
Demand for industrial ingredients is rising. However, current production methods are costly, seasonal, and exposed to geopolitical and climate risks. Meanwhile, bioproduction offers an alternative, but developing high-yield industrial strains has traditionally been a slow and expensive process.
Additionally, baCta aims to address this challenge by enabling more sustainable production of high-value molecules. The company uses AI and precision fermentation to program microorganisms as molecular factories for industrial ingredient manufacturing.
baCta’s Innovative Solution
baCta’s baCtaForge platform combines advances in synthetic biology, robotics, and generative AI. This platform applies bio-based reinforcement learning to reduce development time and costs. For example, the platform can explore genomic regions, long-range interactions, and regulatory pathways often overlooked by conventional engineering.
Furthermore, the new funding will be used to scale up production by validating industrial processes at pilot and commercial stages. The company also plans to expand baCtaForge’s capabilities to additional high-value ingredients.
Conclusion and Future Outlook
In conclusion, baCta’s €7M funding is a significant step towards advancing programmable microbial factories. As the industry enters a phase where microorganisms can serve as programmable molecular factories, baCta is well-positioned to lead the way. Therefore, we can expect to see more sustainable and efficient production of industrial ingredients in the future.
